Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/11/2025

Medication-Overuse Headache Prevention and Management

Risk Factors and Prevention

  • The American College of Physicians recommends limiting use of any acute migraine medication, including those containing barbiturates, caffeine, butalbital, or opioids, to fewer than 10-15 days per month to minimize the risk of medication-overuse headache 1, 2
  • The American Academy of Family Physicians suggests considering preventive migraine therapy if headaches occur more than 2 days per week, and using a headache diary to monitor frequency of medication use 2, 5
  • Medications containing barbiturates, caffeine, butalbital, or opioids carry the highest risk of causing rebound headaches, while NSAIDs (when used less than 15 days/month) carry a lower risk, and newer CGRP antagonists like Ubrelvy have minimal evidence of risk 1, 3, 4

Management Approaches

  • Individual response to medications varies significantly, and treatment should be tailored based on headache characteristics, frequency, and associated symptoms, according to the American College of Physicians 1, 2